Vivo Capital

Founded in 1996, Vivo Capital is a global investment firm focused exclusively on the healthcare sector. Based in Palo Alto, California, with a strong presence in Asia, the firm manages approximately $5.8 billion in assets. Vivo employs a multi-strategy investment model, including venture capital, growth equity, buyouts, and public market investing, to support healthcare companies at all stages.

Its portfolio includes over 430 public and private companies worldwide, covering biotechnology, pharmaceuticals, medical devices, and healthcare services. Vivo Capital is recognized for its deep sector expertise and has partnered with leading healthcare innovators like Sinovac Biotech and WuXi AppTec. The firm’s team integrates scientific, operational, and financial acumen to drive value across its investments.

With a cross-border approach and offices in the U.S. and key Asian markets, Vivo Capital is uniquely positioned to bridge global healthcare ecosystems. Its mission is to back transformative companies that improve patient outcomes and healthcare delivery globally.